Cover
Cover - shares | 9 Months Ended | |
Sep. 30, 2022 | Oct. 25, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-41049 | |
Entity Registrant Name | UserTesting, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 26-0339214 | |
Entity Address, Address Line One | 144 Townsend Street | |
Entity Address, City or Town | San Francisco | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94107 | |
City Area Code | 650 | |
Local Phone Number | 567-5616 | |
Title of 12(b) Security | Common Stock, $0.0001 par value per share | |
Trading Symbol | USER | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 144,713,010 | |
Entity Central Index Key | 0001557127 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 164,618 | $ 178,430 |
Accounts receivable, net | 34,058 | 47,973 |
Costs capitalized to obtain revenue contracts, current | 8,621 | 8,116 |
Prepaid expenses and other current assets | 8,512 | 6,045 |
Total current assets | 215,809 | 240,564 |
Property and equipment, net | 2,916 | 3,257 |
Operating lease right-of-use assets, net | 12,852 | 16,401 |
Intangible assets, net | 449 | 640 |
Goodwill | 8,785 | 8,785 |
Costs capitalized to obtain revenue contracts, non-current | 12,256 | 12,941 |
Other long-term assets | 808 | 540 |
Total assets | 253,875 | 283,128 |
Current liabilities: | ||
Accounts payable | 1,524 | 1,544 |
Contract liabilities | 96,831 | 90,952 |
Operating lease liabilities, current | 5,219 | 5,271 |
Accrued expenses and other current liabilities | 12,536 | 21,799 |
Total current liabilities | 116,110 | 119,566 |
Operating lease liabilities, non-current | 9,346 | 12,996 |
Other long-term liabilities | 887 | 887 |
Total liabilities | 126,343 | 133,449 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value per share: 10,000 shares authorized and no shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | 0 | 0 |
Common stock and capital in excess of par value, $0.0001 par value per share: 2,000,000 shares authorized, and 144,625 and 142,241 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively | 379,848 | 352,881 |
Accumulated deficit | (252,316) | (203,202) |
Total stockholders’ equity | 127,532 | 149,679 |
Total liabilities and stockholders’ equity | $ 253,875 | $ 283,128 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, authorized (in shares) | 2,000,000,000 | 2,000,000,000 |
Common Stock, issued (in shares) | 144,625,000 | 142,241,000 |
Common stock, outstanding (in shares) | 144,625,000 | 142,241,000 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Revenue | ||||
Total revenue | $ 49,408 | $ 38,645 | $ 142,822 | $ 104,914 |
Cost of revenue | ||||
Total cost of revenue | 10,903 | 9,512 | 31,721 | 27,477 |
Gross profit | 38,505 | 29,133 | 111,101 | 77,437 |
Operating expenses: | ||||
Sales and marketing | 29,662 | 23,384 | 93,049 | 62,512 |
Research and development | 10,804 | 9,543 | 33,774 | 29,128 |
General and administrative | 10,980 | 6,492 | 30,981 | 19,817 |
Restructuring | 1,385 | 0 | 1,385 | 0 |
Total operating expenses | 52,831 | 39,419 | 159,189 | 111,457 |
Loss from operations | (14,326) | (10,286) | (48,088) | (34,020) |
Interest income, net | 24 | 29 | 44 | 103 |
Other income (expense), net | (582) | 896 | (562) | 683 |
Loss before provision for income taxes | (14,884) | (9,361) | (48,606) | (33,234) |
Provision for income taxes | 307 | 275 | 508 | 569 |
Net loss | $ (15,191) | $ (9,636) | $ (49,114) | $ (33,803) |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.11) | $ (0.49) | $ (0.34) | $ (1.80) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.11) | $ (0.49) | $ (0.34) | $ (1.80) |
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 144,211 | 19,558 | 143,347 | 18,798 |
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 144,211 | 19,558 | 143,347 | 18,798 |
Subscription | ||||
Revenue | ||||
Total revenue | $ 47,517 | $ 35,951 | $ 135,900 | $ 96,883 |
Cost of revenue | ||||
Total cost of revenue | 8,501 | 7,388 | 24,607 | 21,230 |
Professional services | ||||
Revenue | ||||
Total revenue | 1,891 | 2,694 | 6,922 | 8,031 |
Cost of revenue | ||||
Total cost of revenue | $ 2,402 | $ 2,124 | $ 7,114 | $ 6,247 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands | Total | Common stock and capital in excess of par value | Accumulated deficit |
Balance at beginning of period (in shares) at Dec. 31, 2020 | 110,851,000 | ||
Balance at beginning of period at Dec. 31, 2020 | $ 201,531 | ||
Balance at end of period (in shares) at Sep. 30, 2021 | 110,851,000 | ||
Balance at end of period at Sep. 30, 2021 | $ 201,531 | ||
Balance at beginning of period (in shares) at Dec. 31, 2020 | 17,948,000 | ||
Balance at beginning of period at Dec. 31, 2020 | (140,363) | $ 12,118 | $ (152,481) |
Total stockholders’ equity | |||
Issuance of common stock upon exercise of stock options (in shares) | 2,053,000 | ||
Issuance of common stock upon exercise of stock options | 1,822 | $ 1,822 | |
Stock-based compensation expense | 4,919 | $ 4,919 | |
Net loss | (33,803) | (33,803) | |
Balance at end of period (in shares) at Sep. 30, 2021 | 20,001,000 | ||
Balance at end of period at Sep. 30, 2021 | $ (167,425) | $ 18,859 | (186,284) |
Balance at beginning of period (in shares) at Jun. 30, 2021 | 110,851,000 | ||
Balance at beginning of period at Jun. 30, 2021 | $ 201,531 | ||
Balance at end of period (in shares) at Sep. 30, 2021 | 110,851,000 | ||
Balance at end of period at Sep. 30, 2021 | $ 201,531 | ||
Balance at beginning of period (in shares) at Jun. 30, 2021 | 18,940,000 | ||
Balance at beginning of period at Jun. 30, 2021 | (161,594) | $ 15,054 | (176,648) |
Total stockholders’ equity | |||
Issuance of common stock upon exercise of stock options (in shares) | 1,061,000 | ||
Issuance of common stock upon exercise of stock options | 1,018 | $ 1,018 | |
Stock-based compensation expense | 2,787 | $ 2,787 | |
Net loss | (9,636) | (9,636) | |
Balance at end of period (in shares) at Sep. 30, 2021 | 20,001,000 | ||
Balance at end of period at Sep. 30, 2021 | $ (167,425) | $ 18,859 | (186,284) |
Balance at beginning of period (in shares) at Dec. 31, 2021 | 0 | ||
Balance at beginning of period at Dec. 31, 2021 | $ 0 | ||
Balance at end of period (in shares) at Sep. 30, 2022 | 0 | ||
Balance at end of period at Sep. 30, 2022 | $ 0 | ||
Balance at beginning of period (in shares) at Dec. 31, 2021 | 142,241,000 | 142,241,000 | |
Balance at beginning of period at Dec. 31, 2021 | $ 149,679 | $ 352,881 | (203,202) |
Total stockholders’ equity | |||
Issuance of common stock upon exercise of stock options (in shares) | 1,680,000 | 1,680,000 | |
Issuance of common stock upon exercise of stock options | $ 2,244 | $ 2,244 | |
Issuance of common stock under the employee stock purchase plan (in shares) | 497,000 | ||
Issuance of common stock under the employee stock purchase plan | $ 2,027 | ||
Vesting of restricted stock units (in shares) | 207,000 | ||
Stock-based compensation expense | $ 22,696 | $ 22,696 | |
Net loss | $ (49,114) | (49,114) | |
Balance at end of period (in shares) at Sep. 30, 2022 | 144,625,000 | 144,625,000 | |
Balance at end of period at Sep. 30, 2022 | $ 127,532 | $ 379,848 | (252,316) |
Balance at beginning of period (in shares) at Jun. 30, 2022 | 0 | ||
Balance at beginning of period at Jun. 30, 2022 | $ 0 | ||
Balance at end of period (in shares) at Sep. 30, 2022 | 0 | ||
Balance at end of period at Sep. 30, 2022 | $ 0 | ||
Balance at beginning of period (in shares) at Jun. 30, 2022 | 143,890,000 | ||
Balance at beginning of period at Jun. 30, 2022 | 134,719 | $ 371,844 | (237,125) |
Total stockholders’ equity | |||
Issuance of common stock upon exercise of stock options (in shares) | 559,000 | ||
Issuance of common stock upon exercise of stock options | $ 688 | $ 688 | |
Vesting of restricted stock units (in shares) | 176,000 | ||
Stock-based compensation expense | $ 7,316 | $ 7,316 | |
Net loss | $ (15,191) | (15,191) | |
Balance at end of period (in shares) at Sep. 30, 2022 | 144,625,000 | 144,625,000 | |
Balance at end of period at Sep. 30, 2022 | $ 127,532 | $ 379,848 | $ (252,316) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Cash flows from operating activities: | ||
Net loss | $ (49,114) | $ (33,803) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 1,139 | 1,204 |
Stock-based compensation expense | 22,696 | 4,919 |
Provision for allowance for doubtful accounts | 687 | 154 |
Amortization of costs capitalized to obtain revenue contracts | 6,886 | 4,757 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 13,228 | (7,323) |
Costs capitalized to obtain revenue contracts | (6,706) | (8,969) |
Prepaid expenses and other assets | (2,734) | (2,877) |
Accounts payable | (9) | 366 |
Accrued liabilities | (9,306) | (1,769) |
Contract liabilities | 5,879 | 16,784 |
Other liabilities | 86 | 552 |
Net cash used in operating activities | (17,268) | (26,005) |
Cash flows from investing activities: | ||
Purchase of property and equipment | (713) | (1,955) |
Purchase of intangible assets | 0 | (150) |
Net cash used in investing activities | (713) | (2,105) |
Cash flows from financing activities: | ||
Payment of offering costs | (102) | (4,025) |
Payment of deferred purchase consideration | 0 | (1,766) |
Proceeds from issuance of common stock upon exercise of stock options | 2,244 | 1,822 |
Proceeds from issuance of common stock under the employee stock purchase plan | 2,027 | 0 |
Net cash provided by (used in) financing activities | 4,169 | (3,969) |
Net decrease in cash and cash equivalents | (13,812) | (32,079) |
Cash and cash equivalents, beginning of period | 178,430 | 96,972 |
Cash and cash equivalents, end of period | 164,618 | 64,893 |
Supplemental disclosures of non-cash investing and financing activities: | ||
Purchases of property and equipment included in accounts payable and accrued liabilities | 20 | 107 |
Offering costs in accrued liabilities | $ 0 | $ 1,151 |
Summary of Business and Signifi
Summary of Business and Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Summary of Business and Significant Accounting Policies | Summary of Business and Significant Accounting Policies Description of Business UserTesting, Inc. and its subsidiaries (together, UserTesting or the Company) provide developers, designers, and product managers access to a video-first, enterprise-grade software-as-a-service (SaaS) platform that enables organizations to see and hear the experiences of real people as they narrate their thoughts out loud while engaging with products, designs, apps, processes, concepts, and brands. The Company was incorporated in the state of California and commenced operations on May 30, 2007. In September 2021, the Company was reincorporated in the State of Delaware. Other than the change in corporate domicile, the reincorporation did not result in any change in the business, physical location, management, assets, liabilities, or total stockholders’ equity (deficit) of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management. Additionally, the reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company. The Company is headquartered in San Francisco and has offices located in Atlanta, Sunnyvale, Norway and the United Kingdom. Fiscal Year The Company’s fiscal year ends on December 31. References to fiscal 2021, for example, refer to the fiscal year ended December 31, 2021. Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP) and applicable guidance for interim financial reporting. The condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited financial statements as of that date, but, does not include all disclosures normally included in the complete financial statements prepared in accordance with U.S. GAAP. The accompanying condensed consolidated balance sheet as of September 30, 2022, condensed consolidated statements of operations and convertible preferred stock and stockholders’ equity (deficit) for the three and nine months ended September 30, 2022 and 2021, and cash flows for the nine months ended September 30, 2022 and 2021, and amounts relating to such interim periods included in the accompanying notes to the condensed consolidated financial statements are unaudited and certain information and note disclosures have been condensed or omitted pursuant to applicable guidance for interim financial reporting. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements, and in management’s opinion, include all normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2022 and its results of operations for the three and nine months ended September 30, 2022 and 2021, and cash flows for the nine months ended September 30, 2022 and 2021. The results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results expected for any future annual or interim period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the Securities and Exchange Commission on March 4, 2022. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of UserTesting, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that the Company (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards based on public company effective dates. The Company will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the Company’s total annual gross revenue is at least $1.07 billion, (ii) the last day of the fiscal year following the fifth anniversary of the completion of the Company’s initial public offering (IPO), (iii) the date on which the Company issued more than $1.0 billion in non-convertible debt securities during the prior three-year period, or (iv) the date on which the Company becomes a large accelerated filer. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. However, future events are subject to change and the estimates and judgments are subject to adjustment. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected period of benefit for deferred contract acquisition costs, the determination of standalone selling price (SSP) for its performance obligations, the allowance for doubtful accounts, the useful lives of long-lived intangible assets, the value of the Company’s common stock prior to the IPO and other assumptions used to measure stock-based compensation, the fair value of assets acquired and liabilities assumed for business combinations, lease term and incremental borrowing rate for lease liabilities, and the valuation of deferred income tax assets and uncertain tax positions. Actual results could differ from those estimates. Due to uncertainty in the macroeconomic environment, including as a result of the effects of the COVID-19 pandemic and increasing inflation, there is ongoing disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstances that would require an update to its estimates, judgments or assumptions or a revision to the carrying value of the Company’s assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained. Concentrations of Risks, Significant Customers and Investments The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. The Company maintains its cash and cash equivalents with high-quality financial institutions with investment-grade ratings. A majority of the cash balances are with U.S. banks and are insured up to the Federal Deposit Insurance Corporation limits. The Company has not experienced any losses on its cash and cash equivalents. No single customer accounted for more than 10% of accounts receivable as of September 30, 2022 and December 31, 2021. No single customer accounted for more than 10% of total revenue during the three and nine months ended September 30, 2022 and 2021. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service offerings, of third parties in order to host or operate certain key products and functions of its business. Comprehensive Loss Comprehensive loss is comprised of net loss and other comprehensive income (loss). The Company has no components of other comprehensive income (loss). Therefore, net loss equals comprehensive loss for all periods presented and, accordingly, condensed consolidated statements of comprehensive loss are not presented in a separate statement. Segment Information The Company operates in one operating segment. An operating segment is defined as a component of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker, who is the Company’s Chief Executive Officer. The Company’s chief operating decision maker is responsible for allocating resources and evaluating the Company’s financial performance. Cash and Cash Equivalents The Company considers highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Cash equivalents consist of money market accounts with tiered interest rates and a U.S. government money market fund, which are denominated in U.S. dollars. Fair Value Measurements The Company categorizes assets and liabilities recorded at fair value on its consolidated balance sheets based on the accounting guidance framework for measuring fair value on either a recurring or nonrecurring basis, whereby inputs used in valuation techniques are assigned a hierarchical level. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company measures assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. U.S. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, to measure the fair value: Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability. Financial instruments consist of cash and cash equivalents, accounts receivable and accounts payable. The Company’s cash equivalents consist of money market accounts with tiered interest rates and a U.S. government money market fund, which are carried at fair value. The Company has determined the carrying value to be equal to the fair value and has classified these investments as Level 1 financial instruments. Accounts Receivable, Net Accounts receivable, net, are recorded at the invoiced amount, net of allowance for doubtful accounts, and are not interest bearing nor secured by collateral. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of accounts, considering a combination of factors including the Company’s customers’ financial condition and collection history, the age of open receivables and the current payment terms. Accounts receivable deemed uncollectible are charged against the allowance for doubtful accounts when identified. To date, allowances for doubtful accounts have not been material. Property and Equipment, Net Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of three The following table presents the Company’s property and equipment, net of accumulated depreciation and amortization, by geographic region (in thousands): September 30, December 31, United States $ 2,178 $ 2,738 United Kingdom 711 510 Rest of the world 27 9 Total property and equipment, net $ 2,916 $ 3,257 Impairment of Long-Lived Assets (including Goodwill and Intangible Assets) Long-lived assets with finite lives include property and equipment and acquired intangible assets. The Company evaluates long-lived assets, including acquired intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparing the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds these estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset or asset group exceeds the fair value of the asset or asset group. Goodwill is not amortized but rather tested for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. Goodwill impairment is recognized when the carrying value of the reporting unit exceeds its fair value, in which case an impairment charge is recorded. The Company did not recognize any impairment charges during the three and nine months ended September 30, 2022 and 2021. Deferred Offering Costs Prior to the completion of the IPO in November 2021, deferred offering costs, which mainly consist of direct incremental legal, accounting, and consulting fees relating to the IPO, were capitalized in “Other long-term assets”. Upon completion of the IPO, the deferred offering costs, net of a reimbursement received from underwriters, were reclassified into equity as a reduction against IPO proceeds. Revenue Recognition The Company derives its revenues from two sources: (1) subscription fees from customers accessing the Company’s platform, and from customers paying for additional support; and (2) professional services and training. Revenue is recognized when promised goods or services are transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services, net of any taxes collected from customers (e.g., sales and other indirect taxes), which are subsequently remitted to government authorities. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Subscription Revenue Subscription revenue primarily consists of subscription fees from customer agreements to access the Company’s platform, as well as additional support services. The Company’s customers do not have the ability to take possession of its software. The Company recognizes revenue for subscription fees and additional support services on a straight-line basis over the term of the contract beginning on the date access to the Company’s platform is granted, as the underlying service is a stand-ready performance obligation. Customers may also purchase incremental capacity to the Company’s platform, which is an additional stand-ready performance obligation satisfied and recognized as revenue over the remaining term of the applicable subscription. The Company views its performance obligation as a series of distinct services as the underlying subscription service is made available to the customer on a continuous basis over the contracted period of time, and that are substantially the same and have the same pattern of transfer to the customer. The Company has concluded that each distinct service is satisfied over time, specifically, given that the nature of its promise is not the actual delivery of a specified quantity of service but is rather providing a single service over a period of time. Customers who consume above their committed capacity will be invoiced for overages on a quarterly basis. The Company recognizes the overage fees as variable consideration. Revenue recognized as variable consideration was not material during the three and nine months ended September 30, 2022 and 2021. The Company typically invoices its customers annually. Payment terms generally require that customers pay within 30 days of invoice. Amounts that have been invoiced are recorded in accounts receivable and in deferred revenue or revenue. The Company applies the practical expedient in Topic 606 paragraph 10-32-18 and does not adjust the promised amount of consideration for the effects of a significant financing component for contracts that are one year or less, and none of the Company’s multi-year contracts contain a significant financing component. Professional Services Revenue Professional services revenue primarily consists of fees from delivering research studies, training services and strategy workshops. The Company recognizes revenue from service engagements that occur over a period of time on a proportional performance basis as labor hours are incurred. Significant Judgments - Contracts with Multiple Performance Obligations The Company regularly enters into contracts with customers that include promises to transfer multiple services. For arrangements with multiple services, the Company evaluates whether the individual services qualify as distinct performance obligations. In its assessment of whether a service is a distinct performance obligation, the Company determines whether the customer can benefit from the service on its own or with other readily available resources and whether the service is separately identifiable from other services in the contract. This evaluation requires the Company to assess the nature of each individual service offering and how the services are provided in the context of the contract, including whether the services are significantly integrated, highly interrelated, or significantly modify each other, which may require judgment based on the facts and circumstances of the contract. Contracts that contain multiple performance obligations that are considered distinct require an allocation of the transaction price to each performance obligation based on each performance obligation’s relative standalone selling price (SSP). The SSP is the price at which the Company would sell a promised good or service separately to a customer. In instances where the Company does not sell a product or service separately, establishing SSP requires significant judgment. The Company estimates the SSP by considering available information, prioritizing observable inputs such as historical sales, internally approved pricing guidelines and objectives, and the underlying cost of delivering the performance obligation. Costs Capitalized to Obtain Revenue Contracts The Company capitalizes sales commissions and associated payroll taxes paid to internal sales personnel that are incremental costs resulting from obtaining a non-cancelable contract with a customer. Sales commissions paid upon the initial acquisition of a customer contract are amortized on a straight-line basis over an estimated period of benefit of four years, which is typically longer than the contractual term of the customer contract but reflects the estimated period of benefit. The Company estimates the period of benefit by taking into consideration the estimated customer life, and the technological life of its platform and related significant features. The Company has elected the practical expedient to expense renewal commissions in the period of booking if the period of amortization is one year or less, and it recognizes renewal commissions over the contract term for renewal contracts greater than one year. Sales commissions on renewal contracts are not considered commensurate with sales commissions on new revenue contracts. Amortization of capitalized contract acquisition costs is included in sales and marketing expense in the condensed consolidated statements of operations. The Company periodically reviews these costs capitalized to obtain revenue contracts to determine whether events or changes in circumstances have occurred that could impact the recoverability of the asset. There were no impairment losses recorded during the three and nine months ended September 30, 2022 and 2021. Costs capitalized to obtain revenue contracts earned and capitalized during the three months ended September 30, 2022 and 2021 were $2.2 million and $3.5 million, respectively, and costs capitalized to obtain revenue contracts earned and capitalized during the nine months ended September 30, 2022 and 2021 were $6.7 million and $9.0 million, respectively. Amortization expense for costs capitalized to obtain revenue contracts during the three months ended September 30, 2022 and 2021 was $2.4 million and $1.8 million, respectively, and amortization expense for costs capitalized to obtain revenue contracts during the nine months ended September 30, 2022 and 2021 was $6.9 million and $4.8 million, respectively. Cost of Revenue Subscription Cost of Revenue Subscription cost of revenue consists of three categories of expenses: UserTesting Contributor Network, platform, and support. UserTesting Contributor Network costs consist primarily of contributor payments for the tests completed as well as the cost to operate and support those contributors. Platform costs consist primarily of the cost to support the Company’s platform, including infrastructure-related, hosting, and personnel-related costs, such as salaries, bonus, stock-based compensation expense, and benefits. Support costs include the personnel-related costs, such as salaries, bonus, stock-based compensation expense, and benefits, of employees who directly support customers of the Company’s subscription services and amortization of acquired intangibles. Professional Services Cost of Revenue Professional services cost of revenue consists primarily of personnel-related costs, third-party consulting expenses, and allocated overhead. Software Development Costs Software development costs include costs to develop software to be used to meet internal needs and applications used to deliver the Company’s services. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed and the software will be used to perform the function intended. Costs capitalized for developing such software applications were not material for the three and nine months ended September 30, 2022 and 2021. Research and Development Research and development expenses primarily consist of personnel-related expenses, including stock-based compensation directly associated with the Company’s research and development employees, contractor costs related to third-party development, and allocated overhead. Research and development costs are expensed as incurred. Advertising Costs Advertising costs are expensed as incurred in sales and marketing expense in the condensed consolidated statements of operations and were $2.0 million and $3.0 million for the three months ended September 30, 2022 and 2021, respectively, and $7.3 million and $7.2 million for the nine months ended September 30, 2022 and 2021, respectively. Leases The Company categorizes lease agreements at their inception as either operating or finance leases. Operating lease right-of-use (ROU) assets and related liabilities are included in “Operating lease right-of-use assets,” “Operating lease liabilities, current,” and “Operating lease liabilities, non-current” in the Company’s condensed consolidated balance sheets. The Company did not have any finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date, including credit premiums on its corporate borrowings, in determining the present value of lease payments. The operating lease ROU asset also includes any advance lease payments made and excludes lease incentives, where applicable. The Company’s lease terms may contain renewal and extension options of up to three years and early termination features. The Company does not include renewal or extension options or early termination features in its determination of the lease term to the extent they are not reasonably certain at lease commencement. Lease expense for lease payments to the extent they are fixed is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor to the extent the charges are variable. The Company has elected to combine non-lease components with lease components for the purposes of calculating the ROU asset and liabilities, to the extent they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease costs. In addition, the Company does not recognize ROU assets and lease liabilities for short-term leases, which have a lease term of 12 months or less at the commencement of the lease. In addition, the Company subleases its unoccupied facility to a third party. Such sublease has been classified as an operating lease. Any impairment to the associated ROU assets, leasehold improvements, or other assets as a result of a sublease is recognized in the period the sublease is executed and recorded in the condensed consolidated statements of operations. The Company recognizes sublease income on a straight-line basis over the sublease term. Stock-Based Compensation The Company has a stock incentive plan under which equity awards such as stock options, restricted stock awards (RSAs), and restricted stock units (RSUs) are granted to employees, directors, and/or consultants. Stock-based compensation expense related to equity awards is recognized based on the fair value of the awards on the date of grant. The fair value of each stock option is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of subjective assumptions, including the fair value of the underlying common stock, risk-free interest rates, the expected term of the option, expected volatility, and expected dividend yield. The expected term of the stock options is based on the average period the stock options are expected to remain outstanding, calculated as the midpoint of the option’s vesting term and the contractual expiration period, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The expected stock price volatility for the Company’s stock was determined by examining the historical volatilities of its industry peers as the Company did not have a relevant trading history of its common stock. The risk-free interest rate was calculated using the average of the published interest rates of U.S. Treasury zero-coupon issues with maturities that approximate the expected term. The dividend yield assumption is zero as the Company has no history of, nor plans of, dividend payments. The fair value of each RSA and RSU is estimated based on the fair value of the Company’s common stock on the date of grant. The related stock-based compensation expense for time-based equity awards is recognized on a straight-line basis over the corresponding requisite service period of the awards, which is generally four years. The Company also has a 2021 Employee Stock Purchase Plan (2021 ESPP) under which stock purchase rights are granted to employees. Stock-based compensation expense related to stock purchase rights under the 2021 ESPP is recognized based on the fair value of the awards on the date of grant. The fair value of each stock purchase right under the 2021 ESPP is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of assumptions, including the fair value of the underlying common stock, risk-free interest rates, the applicable purchase periods within an offering period, expected volatility, and expected dividend yield. The related stock-based compensation expense for stock purchase rights under the 2021 ESPP is recognized on a straight-line basis over the award’s requisite service period, which is an offering period. The Company accounts for forfeitures as they occur. Prior to the IPO, the fair value of the Company’s common stock underlying the awards was determined by the Company’s board of directors with input from management and third-party valuation specialists. The board of directors determined the fair value of the common stock by considering a number of objective and subjective factors including: the valuation of comparable companies, the Company’s operating and financial performance, the lack of liquidity of common stock, transactions in the Company’s common stock, and general and industry specific economic outlook, amongst other factors. After the IPO, the Company uses the publicly quoted price as reported on the New York Stock Exchange as the fair value of its common stock. In September 2021, the Company granted RSUs which vest based upon the satisfaction of both a service-based condition and a liquidity event-based condition. The service-based vesting condition for these awards is generally satisfied over four years. The liquidity event-based vesting condition is satisfied upon the occurrence of a qualifying event, which is generally defined as an underwritten initial public offering or a change in control transaction. The related stock-based compensation expense for these awards is recognized using an accelerated attribution method from the time it is deemed probable that the liquidity event-based vesting condition will be met through the time the service-based vesting condition has been achieved. The Company began recognizing stock-based compensation expense for these RSUs in November 2021 when the liquidity event-based vesting condition applicable to these RSUs was satisfied upon the effectiveness of the Company’s IPO. Foreign Currency The functional currency of the Company’s foreign subsidiaries is the U.S. Dollar (USD). Monetary assets and liabilities are remeasured using foreign currency exchange rates at the end of the period, and non-monetary assets and liabilities are remeasured based on historical exchange rates. Gains and losses due to foreign currency are the result of either the remeasurement of subsidiary balances or transactions denominated in currencies other than the foreign subsidiaries’ functional currency and are included in other income (expense), net in the Company’s condensed consolidated statements of operations. Income Taxes The Company uses the asset and liability method of accounting for income taxes, in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the yea |
Revenue
Revenue | 9 Months Ended |
Sep. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Contract Balances The Company receives payments from customers based on a billing schedule as established in its customer contracts. Accounts receivable are recorded when the Company contractually has the right to consideration. There were no impairment losses recorded during the three and nine months ended September 30, 2022 and 2021. Contract liabilities consisted of the following (in thousands): September 30, December 31, Deferred revenue $ 91,714 $ 84,494 Customer deposits 5,117 6,458 Contract liabilities $ 96,831 $ 90,952 Deferred revenue represents billings under noncancellable contracts that have been invoiced in advance of revenue recognition, and the balance is recognized as revenue when transfer of control to customers has occurred or services have been provided. Customer deposits consist of billings for anticipated revenue generating activities in advance of the start of the contractual term or for the portion of a contract term that is subject to cancellation and refund. Revenue is deferred when the Company has the right to invoice in advance of performance under a customer contract. The current portion of deferred revenue and customer deposits are recognized during the following 12-month period, provided the customers with cancellable contracts do not invoke their termination rights. As of September 30, 2022 and December 31, 2021, the Company’s contract liabilities were $96.8 million and $91.0 million, respectively. The amount of revenue recognized during the nine months ended September 30, 2022 and 2021 that was included in contract liabilities at the beginning of each period was $83.6 million and $57.5 million, respectively. Remaining Performance Obligations The terms of the Company’s subscription agreements are primarily annual and, to a lesser extent, multi-year. The Company's subscription agreements are generally noncancellable. Revenue allocated to remaining performance obligations represents noncancellable contracted revenue that has not yet been recognized and includes deferred revenue and unbilled amounts that will be recognized as revenue in future periods. Unbilled portions of the remaining performance obligation denominated in foreign currencies are revalued each period based on the period end exchange rates. Cancellable remaining performance obligations, which includes customer deposits, are not included in the Company’s remaining performance obligation disclosure. As of September 30, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $119.8 million. As of September 30, 2022, the Company expects to recognize the significant majority of its remaining performance obligations as revenue over the subsequent twelve months, and the remainder over 24 months. The remaining performance obligations exclude customer deposits and unbilled amounts of cancellable contracted revenue of $5.9 million as of September 30, 2022. Disaggregation of Revenue The following table sets forth revenue by geographic area for the periods presented: Three Months Ended September 30, 2022 2021 (in thousands) % (in thousands) % United States $ 38,845 79 % $ 31,444 81 % International 10,563 21 7,201 19 Total revenue $ 49,408 100 % $ 38,645 100 % Nine Months Ended September 30, 2022 2021 (in thousands) % (in thousands) % United States $ 113,278 79 % $ 86,082 82 % International 29,544 21 18,832 18 Total revenue $ 142,822 100 % $ 104,914 100 % No single country other than the United States represented 10% or more of the Company’s revenue during the three and nine months ended September 30, 2022 and 2021. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The Company follows guidance provided in ASC 820, Fair Value Measurement, for valuation of financial assets and financial liabilities and for nonfinancial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. This guidance also establishes a framework for measuring fair value and expands disclosures about fair value measurements. The Company’s investment portfolio consists of tiered interest money market accounts and a U.S. government money market fund amounting to $117.9 million as of September 30, 2022 and tiered interest money market accounts amounting to $33.6 million as of December 31, 2021, which are carried at fair value. The Company has determined the carrying value to be equal to the fair value and has classified these investments as Level 1 financial instruments. There were no transfers in or out of Level 3 during the periods presented. |
Consolidated Balance Sheet Comp
Consolidated Balance Sheet Components | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Consolidated Balance Sheet Components | Consolidated Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): September 30, December 31, Computer, equipment, and software $ 2,879 $ 2,632 Furniture and fixtures 393 357 Leasehold improvements 2,067 1,822 Property and equipment, gross 5,339 4,811 Less: accumulated depreciation (2,423) (1,554) Property and equipment, net $ 2,916 $ 3,257 Depreciation expense was $0.3 million and $0.2 million for the three months ended September 30, 2022 and 2021, respectively, and $0.9 million and $0.4 million for the nine months ended September 30, 2022 and 2021, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, December 31, Sales tax payable $ 641 $ 5,528 Accrued compensation and benefits 4,159 7,218 Accrued tax liabilities 2,544 2,805 ESPP liability 1,559 466 Others 3,633 5,782 Accrued expenses and other current liabilities $ 12,536 $ 21,799 |
Goodwill and Intangible Assets,
Goodwill and Intangible Assets, Net | 9 Months Ended |
Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets, Net | Goodwill and Intangible Assets, Net Goodwill As of September 30, 2022 and December 31, 2021, goodwill was $8.8 million. Goodwill represents the excess of the purchase price over the fair value of net assets acquired from Teston AS in 2020. Goodwill amounts are not amortized but are rather tested for impairment at least annually during the fourth quarter or more frequently if events or changes in circumstances indicate that goodwill may be impaired. Intangible Assets, Net Intangible assets, net of $0.4 million and $0.6 million as of September 30, 2022 and December 31, 2021, respectively, consisted of developed technology. Amortization expense of acquired intangible assets was $0.1 million and $0.3 million for the three months ended September 30, 2022 and 2021, respectively, and $0.2 million and $0.8 million for the nine months ended September 30, 2022 and 2021, respectively. |
Debt
Debt | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
Debt | Debt Revolving Line of Credit On June 18, 2021, the Company entered into a Fifth Loan and Security Modification Agreement with a lender, which provides the Company with the ability to borrow up to $5.5 million, maturing on June 18, 2024, and which accrues interest at a per annum rate equal to the greater of 3.25% and prime rate as reported in The Wall Street Journal or such other rate of interest publicly announced from time to time by the lender as its prime rate (6.25% at September 30, 2022 and 3.25% at December 31, 2021). The credit facility is secured by a security interest on substantially all the Company’s assets and is subject to certain financial covenants. The Company may use the proceeds of future borrowings under the credit facility for general corporate purposes which may include, without limitation, financing the consideration for and fees, costs and expenses related to an acquisition. Pursuant to this agreement, the Company is required to maintain at all times unrestricted cash with the lender in an amount equal to at least $5.5 million. As of September 30, 2022 and December 31, 2021, the Company had no outstanding borrowings pursuant to the above credit facility and was in compliance with the above agreement with the lender. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Operating Leases The Company leases its office facilities in the United States and the United Kingdom under non-cancellable agreements that expire at various dates through August 2025. Total operating lease costs, excluding short-term lease costs, variable lease costs, and sublease income, each of which were immaterial for the periods presented, were as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Operating lease costs $ 1,496 $ 1,365 $ 4,499 $ 4,325 Supplemental cash flow information related to leases were as follows (in thousands): Nine Months Ended September 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,635 $ 3,931 Right-of-use assets obtained in exchange for lease obligations: Operating leases 372 1,010 The weighted-average remaining lease term and discount rate for the Company’s operating leases were as follows: September 30, December 31, Weighted-average remaining lease term 2.7 years 3.3 years Weighted-average discount rate 5.8% 5.8% The total remaining lease payments under non-cancelable operating leases as of September 30, 2022 were as follows (in thousands): Remainder of 2022 $ 1,522 2023 5,696 2024 5,147 2025 3,368 Total undiscounted lease payments 15,733 Less imputed interest (1,168) Present value of operating lease liabilities $ 14,565 Other Contractual Commitments The Company’s other contractual commitments relate mainly to third-party cloud infrastructure agreements and online services agreements. There were no material contractual obligations that were entered into during the three and nine months ended September 30, 2022 that were outside the ordinary course of business. Warranties, Indemnification, and Contingencies The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements. In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments. In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid. Legal Proceedings In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. The Company makes a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. In general, the resolution of a legal matter could be material to the Company’s financial condition or cash flows, or both, or could otherwise adversely affect the Company’s operating results. The outcomes of legal proceedings and other contingencies are, however, inherently unpredictable and subject to significant uncertainties. At this time, the Company does not have any such matters that, if resolved unfavorably, would have a material impact on its financial condition, results of operations or cash flows. |
Stockholders_ Equity and Equity
Stockholders’ Equity and Equity Incentive Plan | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
Stockholders’ Equity and Equity Incentive Plan | Stockholders’ Equity and Equity Incentive Plan Common Stock and Preferred Stock In connection with the Company’s IPO in November 2021, the Company’s Restated Certificate of Incorporation became effective, which authorized the issuance of 2,000,000,000 shares of common stock with a par value of $0.0001 per share and 10,000,000 shares of preferred stock with a par value of $0.0001 per share. The Company had the following shares of common stock reserved for future issuance (in thousands): September 30, December 31, Outstanding stock awards to purchase common stock 26,021 25,181 Stock awards available for future grants 20,538 16,154 Shares available for issuance under 2021 ESPP 4,024 3,100 50,583 44,435 Equity Incentive Plan In June 2007, the Company adopted the 2007 Equity Incentive Plan (the 2007 Plan). Under the 2007 Plan, the Company originally authorized the issuance of 500,000 shares. In March 2013, the board of directors adopted the 2013 Equity Incentive Plan (the 2013 Plan) and ceased granting awards under the 2007 Plan. Upon the effective date of the suspension of the 2007 Plan, all remaining shares available for issuance under the 2007 Plan became available for issuance under the 2013 Plan and any options that expired or were forfeited automatically become available under the 2013 Plan. In October 2021, the Company’s board of directors and stockholders approved the adoption of the 2021 Equity Incentive Plan (2021 Plan), which became effective in connection with the IPO. Under the 2021 Plan, 15,700,000 shares of the Company’s common stock are initially reserved for future issuance. Upon the effective date of the 2021 Plan, any remaining shares available for issuance under the Company’s 2013 Plan were added to the shares of the Company’s common stock reserved for issuance under its 2021 Plan, and the Company ceased granting awards under the 2013 Plan. The number of shares reserved for issuance under the 2021 Plan will increase automatically on January 1 of each of the first ten The 2021 Plan authorizes the award of both incentive stock options and nonqualified stock options, as well as the award of RSAs, RSUs, stock appreciation rights, and performance and stock bonus awards. Pursuant to the 2021 Plan, incentive stock options may be granted only to employees. The exercise price of an option cannot be less than 100% of the fair value of one share of common stock on the date of grant and the exercise price of any incentive stock option granted to a 10% stockholder cannot be less than 110% of the fair value of one share of common stock on the date of grant. Options are exercisable over periods not to exceed ten years from the date of grant (five years for incentive stock options granted to stockholders owning greater than 10% of all classes). Vesting terms for options is generally four years. The Company may grant all other types of awards to its employees, directors, and consultants. As of September 30, 2022 and December 31, 2021, 20,538,259 and 16,153,747 shares of common stock have been reserved for issuance under the 2021 Plan, respectively. In October 2021, the Company’s board of directors and stockholders approved the adoption of the 2021 ESPP, which became effective in connection with the IPO. Under the 2021 ESPP, 3,100,000 shares of the Company’s common stock are initially reserved for future issuance. The number of shares reserved for issuance and sale under the 2021 ESPP will increase automatically on January 1 of each of the first ten Under the 2021 ESPP, eligible employees will be offered the option to purchase shares of the Company’s common stock at a discount over a series of offering periods through accumulated payroll deductions over the period. Each offering period may itself consist of one or more purchase periods. No offering period may be longer than 27 months. The purchase price for shares purchased under the 2021 ESPP during any given purchase period will be 85% of the lesser of the fair market value of the Company’s common stock on (i) the first day of the applicable offering period or (ii) the last day of the purchase period. As of September 30, 2022 and December 31, 2021, 4,024,434 and 3,100,000 shares of common stock have been reserved for issuance under the 2021 ESPP, respectively. The following table summarizes the stock option activity during the nine months ended September 30, 2022 (in thousands, except per share data): Options Outstanding Outstanding Stock options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value Balance as of December 31, 2021 22,690 $ 1.71 7.56 $ 153,883 Exercised (1,680) 1.34 8,431 Forfeited (1,013) 3.17 Expired (53) 1.66 Balance as of September 30, 2022 19,944 1.66 6.82 48,015 Vested and exercisable: September 30, 2022 14,435 $ 1.22 6.35 $ 39,336 December 31, 2021 11,917 $ 0.96 6.66 $ 88,893 No options were granted during the nine months ended September 30, 2022. The weighted-average grant date fair value of options granted during the nine months ended September 30, 2021 was $4.05. The following table summarizes the RSU activity during the nine months ended September 30, 2022 (in thousands, except per share data): Restricted Stock Units Number of Shares Weighted-Average Grant Date Fair Value Balance as of December 31, 2021 2,491 $ 16.11 Granted 4,707 9.21 Vested (207) 9.70 Forfeited (914) 12.12 Balance as of September 30, 2022 6,077 11.59 There was no RSA activity during the nine months ended September 30, 2022. In 2021, the Company began granting RSUs to its employees and directors. These RSUs generally vest upon the satisfaction of a service-based vesting condition with a vesting period of generally four years. In September 2021, the Company granted RSUs settleable for 2,490,942 shares of its common stock with a weighted average grant date fair value of $16.11 per share, which vested based upon the satisfaction of both a service-based condition and a liquidity event-based condition. The Company recognized compensation expense for these RSUs using an accelerated attribution method beginning in November 2021 when the liquidity event-based vesting condition applicable to these RSUs was satisfied upon the effectiveness of the Company’s IPO. The Company recognized stock-based compensation expense of $3.3 million and $11.9 million associated with these RSUs for the three and nine months ended September 30, 2022, respectively. Stock-Based Compensation The assumptions used under the Black-Scholes option pricing model to calculate the estimated fair value of stock options granted to employees are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Fair value of common stock * $ 10.97 — 17.04 * $ 3.88 — 17.04 Risk-free interest rate * 0.94% — 1.00% * 0.94% — 1.05% Expected term (years) * 5.84 — 6.08 * 5.73 — 6.08 Expected volatility * 55.24% — 56.82% * 54.04% — 56.82% Expected dividend yield * None * None ____________ * No stock options were granted during the periods presented. The following table summarizes the assumptions used to calculate the estimated fair value of stock purchase rights granted under the 2021 ESPP using the Black-Scholes-Merton option pricing model: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Fair value of common stock * * $ 4.52 * Risk-free interest rate * * 1.54% — 2.66% * Expected term (years) * * 0.49 — 1.99 * Expected volatility * * 53.74% — 60.64% * Expected dividend yield * * None * ____________ * No stock purchase rights were granted under the 2021 ESPP during the periods presented. The total stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of revenue: Subscription $ 211 $ 11 $ 553 $ 30 Professional services 239 78 701 160 Operating expenses: Sales and marketing 2,920 404 9,057 1,079 Research and development 1,384 237 4,574 620 General and administrative 2,562 2,057 7,811 3,030 Total stock-based compensation expense $ 7,316 $ 2,787 $ 22,696 $ 4,919 As of September 30, 2022, the unrecognized stock-based compensation expense related to outstanding unvested stock options was $12.1 million, which is expected to be recognized over a weighted-average period of 2.5 years. As of September 30, 2022, the unrecognized stock-based compensation expense related to outstanding RSUs was $50.5 million which is expected to be recognized over the remaining weighted-average vesting period of approximately 3.0 years. As of September 30, 2022, the unrecognized stock-based compensation expense related to outstanding stock purchase rights granted under the 2021 ESPP was $2.8 million which is expected to be recognized over 1.6 years. |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company’s quarterly tax provision is based upon an estimated annual effective tax rate. The Company’s provision for income taxes has not been historically significant to the business as the Company has incurred U.S. operating losses to date. The provision for income taxes consists primarily of state taxes and foreign taxes in jurisdictions in which the Company conducts business. The Company’s provision for income taxes was $0.3 million and $0.3 million for the three months ended September 30, 2022 and 2021, respectively, and $0.5 million and $0.6 million for the nine months ended September 30, 2022 and 2021, respectively, with an effective tax rate of (2.1)% and (2.9)% for the three months ended September 30, 2022 and 2021, respectively, and an effective tax rate of (1.0)% and (1.7)% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the U.S. statutory tax rate primarily due to the valuation allowance on the Company’s U.S. deferred tax assets. The Company maintains a full valuation allowance against its U.S. deferred tax assets as of September 30, 2022. It regularly assesses the need for a valuation allowance against its net deferred tax assets. In making that assessment, the Company considers both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. Due to cumulative losses over recent years and based on all available evidence, the Company has determined that it is more likely than not that its U.S. deferred tax assets will not be realized as of September 30, 2022. The Company has elected to record taxes associated with its Global Intangible Low-Taxed Income as period costs if and when incurred. On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 (the Inflation Act) into law. The Inflation Act contains certain tax measures, including a corporate alternative minimum tax of 15% on some large corporations and an excise tax of 1% on corporate stock buy-backs. The Company does not expect the new law to have a material impact on its condensed consolidated financial statements. |
Net Loss Per Share
Net Loss Per Share | 9 Months Ended |
Sep. 30, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except share and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders, basic and diluted $ (15,191) $ (9,636) $ (49,114) $ (33,803) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 144,211 19,558 143,347 18,798 Net loss per share attributable to common stockholders, basic and diluted $ (0.11) $ (0.49) $ (0.34) $ (1.80) The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows (in thousands): September 30, 2022 2021 Convertible preferred shares — 110,851 Options and RSUs issued and outstanding 26,021 26,144 ESPP 243 — Total antidilutive securities 26,264 136,995 |
Employee Benefit Plans
Employee Benefit Plans | 9 Months Ended |
Sep. 30, 2022 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Employee Benefit PlansThe Company maintains a retirement savings plan, established pursuant to Section 401(k) of the Internal Revenue Code of 1986, as amended (the Code). Participants may contribute up to applicable annual Code limits. The plan allows the Company to make matching contributions to eligible participants. The Company provided a matching contribution up to 4% of eligible participants’ compensation for the three and nine months ended September 30, 2022 and 2021. The plan provides for automatic salary deferrals of 5% of compensation each year. Participants are permitted to change their salary deferral percentage and waive the automatic deferral provision. All participants’ deferrals, rollovers and matching contributions are 100% vested when contributed. The Company recognized $0.8 million and $0.7 million in expenses related to the 401(k) match for the three months ended September 30, 2022 and 2021, respectively, and $2.6 million and $2.2 million for the nine months ended September 30, 2022 and 2021, respectively. |
Restructuring
Restructuring | 9 Months Ended |
Sep. 30, 2022 | |
Restructuring and Related Activities [Abstract] | |
Restructuring | RestructuringIn July 2022, management approved, committed to and initiated a plan of termination that resulted in a reduction in the Company’s total full-time employee workforce by approximately 7%. The Company substantially completed this workforce reduction in the third quarter of 2022. As a result of this workforce reduction, the Company incurred a pre-tax cash charge of approximately $1.4 million for one-time termination benefits, which substantially consist of severance and were recorded to the restructuring expense line item within the Company’s condensed consolidated statements of operations. All charges associated with the workforce reduction were incurred and substantially paid in the third quarter of 2022. |
Subsequent Event
Subsequent Event | 9 Months Ended |
Sep. 30, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Event | Subsequent Event On October 26, 2022, the Company entered into a definitive agreement to be acquired by Thoma Bravo, a leading software investment firm, and Sunstone Partners for $7.50 per share, in an all-cash transaction valued at approximately $1.3 billion. The transaction, which was unanimously approved by the Company’s board of directors, is currently expected to close in the first half of 2023, subject to customary closing conditions, including approval by the Company’s stockholders and the receipt of required regulatory approvals. Upon completion of the transaction, the Company’s common stock will no longer be publicly listed and the Company will become a privately held company. The agreement includes a “go-shop” period expiring at 11:59 p.m. Pacific time on December 10, 2022, which allows the Company’s board of directors and its advisors to actively initiate, solicit and consider alternative acquisition proposals from third parties. The Company’s board of directors will have the right to terminate the merger agreement to enter into a superior proposal subject to the terms and conditions of the merger agreement. There can be no assurance that this “go-shop” will result in a superior proposal, and the Company does not intend to disclose developments with respect to the solicitation process unless and until it determines such disclosure is appropriate or otherwise required. Pursuant to the agreement, the Company may be required to pay a termination fee of up to approximately $33.9 million, if the agreement is terminated under certain circumstances, and may be entitled to receipt of a termination fee of approximately $67.8 million, if the agreement is terminated under certain circumstances. |
Summary of Business and Signi_2
Summary of Business and Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP) and applicable guidance for interim financial reporting. The condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited financial statements as of that date, but, does not include all disclosures normally included in the complete financial statements prepared in accordance with U.S. GAAP. The accompanying condensed consolidated balance sheet as of September 30, 2022, condensed consolidated statements of operations and convertible preferred stock and stockholders’ equity (deficit) for the three and nine months ended September 30, 2022 and 2021, and cash flows for the nine months ended September 30, 2022 and 2021, and amounts relating to such interim periods included in the accompanying notes to the condensed consolidated financial statements are unaudited and certain information and note disclosures have been condensed or omitted pursuant to applicable guidance for interim financial reporting. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements, and in management’s opinion, include all normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2022 and its results of operations for the three and nine months ended September 30, 2022 and 2021, and cash flows for the nine months ended September 30, 2022 and 2021. The results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results expected for any future annual or interim period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the Securities and Exchange Commission on March 4, 2022. |
Principles of Consolidation | Principles of ConsolidationThe accompanying unaudited condensed consolidated financial statements include the accounts of UserTesting, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. |
Emerging Growth Company Status | Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that the Company (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards based on public company effective dates. The Company will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the Company’s total annual gross revenue is at least $1.07 billion, (ii) the last day of the fiscal year following the fifth anniversary of the completion of the Company’s initial public offering (IPO), (iii) the date on which the Company issued more than $1.0 billion in non-convertible debt securities during the prior three-year period, or (iv) the date on which the Company becomes a large accelerated filer. |
Use of Estimates | Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. However, future events are subject to change and the estimates and judgments are subject to adjustment. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected period of benefit for deferred contract acquisition costs, the determination of standalone selling price (SSP) for its performance obligations, the allowance for doubtful accounts, the useful lives of long-lived intangible assets, the value of the Company’s common stock prior to the IPO and other assumptions used to measure stock-based compensation, the fair value of assets acquired and liabilities assumed for business combinations, lease term and incremental borrowing rate for lease liabilities, and the valuation of deferred income tax assets and uncertain tax positions. Actual results could differ from those estimates. Due to uncertainty in the macroeconomic environment, including as a result of the effects of the COVID-19 pandemic and increasing inflation, there is ongoing disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstances that would require an update to its estimates, judgments or assumptions or a revision to the carrying value of the Company’s assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained. |
Concentration Risks, Significant Customers and Investments | Concentrations of Risks, Significant Customers and Investments The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. The Company maintains its cash and cash equivalents with high-quality financial institutions with investment-grade ratings. A majority of the cash balances are with U.S. banks and are insured up to the Federal Deposit Insurance Corporation limits. The Company has not experienced any losses on its cash and cash equivalents. No single customer accounted for more than 10% of accounts receivable as of September 30, 2022 and December 31, 2021. No single customer accounted for more than 10% of total revenue during the three and nine months ended September 30, 2022 and 2021. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service offerings, of third parties in order to host or operate certain key products and functions of its business. |
Comprehensive Loss | Comprehensive Loss Comprehensive loss is comprised of net loss and other comprehensive income (loss). The Company has no components of other comprehensive income (loss). Therefore, net loss equals comprehensive loss for all periods presented and, accordingly, condensed consolidated statements of comprehensive loss are not presented in a separate statement. |
Segment Information | Segment Information The Company operates in one operating segment. An operating segment is defined as a component of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker, who is the |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Cash equivalents consist of money market accounts with tiered interest rates and a U.S. government money market fund, which are denominated in U.S. dollars. |
Fair Value Measurements | Fair Value Measurements The Company categorizes assets and liabilities recorded at fair value on its consolidated balance sheets based on the accounting guidance framework for measuring fair value on either a recurring or nonrecurring basis, whereby inputs used in valuation techniques are assigned a hierarchical level. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company measures assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. U.S. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, to measure the fair value: Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability. Financial instruments consist of cash and cash equivalents, accounts receivable and accounts payable. The Company’s cash equivalents consist of money market accounts with tiered interest rates and a U.S. government money market fund, which are carried at fair value. The Company has determined the carrying value to be equal to the fair value and has classified these investments as Level 1 financial instruments. |
Accounts Receivable, Net | Accounts Receivable, Net Accounts receivable, net, are recorded at the invoiced amount, net of allowance for doubtful accounts, and are not interest bearing nor secured by collateral. The allowance for doubtful accounts is based on the Company’s assessment of the collectability of accounts, considering a combination of factors including the Company’s customers’ financial condition and collection history, the age of open receivables and the current payment terms. Accounts receivable deemed uncollectible are charged against the allowance for doubtful accounts when identified. To date, allowances for doubtful accounts have not been material. |
Property and Equipment, Net | Property and Equipment, Net Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of three |
Impairment of Long-Lived Assets (including Goodwill and Intangible Assets) | Impairment of Long-Lived Assets (including Goodwill and Intangible Assets) Long-lived assets with finite lives include property and equipment and acquired intangible assets. The Company evaluates long-lived assets, including acquired intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparing the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds these estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset or asset group exceeds the fair value of the asset or asset group. Goodwill is not amortized but rather tested for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. Goodwill impairment is recognized when the carrying value of the reporting unit exceeds its fair value, in which case an impairment charge is recorded. The Company did not recognize any impairment charges during the three and nine months ended September 30, 2022 and 2021. |
Deferred Offering Costs | Deferred Offering Costs Prior to the completion of the IPO in November 2021, deferred offering costs, which mainly consist of direct incremental legal, accounting, and consulting fees relating to the IPO, were capitalized in “Other long-term assets”. Upon completion of the IPO, the deferred offering costs, net of a reimbursement received from underwriters, were reclassified into equity as a reduction against IPO proceeds. |
Revenue Recognition | Revenue Recognition The Company derives its revenues from two sources: (1) subscription fees from customers accessing the Company’s platform, and from customers paying for additional support; and (2) professional services and training. Revenue is recognized when promised goods or services are transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services, net of any taxes collected from customers (e.g., sales and other indirect taxes), which are subsequently remitted to government authorities. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Subscription Revenue Subscription revenue primarily consists of subscription fees from customer agreements to access the Company’s platform, as well as additional support services. The Company’s customers do not have the ability to take possession of its software. The Company recognizes revenue for subscription fees and additional support services on a straight-line basis over the term of the contract beginning on the date access to the Company’s platform is granted, as the underlying service is a stand-ready performance obligation. Customers may also purchase incremental capacity to the Company’s platform, which is an additional stand-ready performance obligation satisfied and recognized as revenue over the remaining term of the applicable subscription. The Company views its performance obligation as a series of distinct services as the underlying subscription service is made available to the customer on a continuous basis over the contracted period of time, and that are substantially the same and have the same pattern of transfer to the customer. The Company has concluded that each distinct service is satisfied over time, specifically, given that the nature of its promise is not the actual delivery of a specified quantity of service but is rather providing a single service over a period of time. Customers who consume above their committed capacity will be invoiced for overages on a quarterly basis. The Company recognizes the overage fees as variable consideration. Revenue recognized as variable consideration was not material during the three and nine months ended September 30, 2022 and 2021. The Company typically invoices its customers annually. Payment terms generally require that customers pay within 30 days of invoice. Amounts that have been invoiced are recorded in accounts receivable and in deferred revenue or revenue. The Company applies the practical expedient in Topic 606 paragraph 10-32-18 and does not adjust the promised amount of consideration for the effects of a significant financing component for contracts that are one year or less, and none of the Company’s multi-year contracts contain a significant financing component. Professional Services Revenue Professional services revenue primarily consists of fees from delivering research studies, training services and strategy workshops. The Company recognizes revenue from service engagements that occur over a period of time on a proportional performance basis as labor hours are incurred. Significant Judgments - Contracts with Multiple Performance Obligations The Company regularly enters into contracts with customers that include promises to transfer multiple services. For arrangements with multiple services, the Company evaluates whether the individual services qualify as distinct performance obligations. In its assessment of whether a service is a distinct performance obligation, the Company determines whether the customer can benefit from the service on its own or with other readily available resources and whether the service is separately identifiable from other services in the contract. This evaluation requires the Company to assess the nature of each individual service offering and how the services are provided in the context of the contract, including whether the services are significantly integrated, highly interrelated, or significantly modify each other, which may require judgment based on the facts and circumstances of the contract. Contracts that contain multiple performance obligations that are considered distinct require an allocation of the transaction price to each performance obligation based on each performance obligation’s relative standalone selling price (SSP). The SSP is the price at which the Company would sell a promised good or service separately to a customer. In instances where the Company does not sell a product or service separately, establishing SSP requires significant judgment. The Company estimates the SSP by considering available information, prioritizing observable inputs such as historical sales, internally approved pricing guidelines and objectives, and the underlying cost of delivering the performance obligation. |
Costs Capitalized to Obtain Revenue Contracts | Costs Capitalized to Obtain Revenue Contracts The Company capitalizes sales commissions and associated payroll taxes paid to internal sales personnel that are incremental costs resulting from obtaining a non-cancelable contract with a customer. Sales commissions paid upon the initial acquisition of a customer contract are amortized on a straight-line basis over an estimated period of benefit of four years, which is typically longer than the contractual term of the customer contract but reflects the estimated period of benefit. The Company estimates the period of benefit by taking into consideration the estimated customer life, and the technological life of its platform and related significant features. The Company has elected the practical expedient to expense renewal commissions in the period of booking if the period of amortization is one year or less, and it recognizes renewal commissions over the contract term for renewal contracts greater than one year. Sales commissions on renewal contracts are not considered commensurate with sales commissions on new revenue contracts. Amortization of capitalized contract acquisition costs is included in sales and marketing expense in the condensed consolidated statements of operations. The Company periodically reviews these costs capitalized to obtain revenue contracts to determine whether events or changes in circumstances have occurred that could impact the recoverability of the asset. There were no impairment losses recorded during the three and nine months ended September 30, 2022 and 2021. Costs capitalized to obtain revenue contracts earned and capitalized during the three months ended September 30, 2022 and 2021 were $2.2 million and $3.5 million, respectively, and costs capitalized to obtain revenue contracts earned and capitalized during the nine months ended September 30, 2022 and 2021 were $6.7 million and $9.0 million, respectively. Amortization expense for costs capitalized to obtain revenue contracts during the three months ended September 30, 2022 and 2021 was $2.4 million and $1.8 million, respectively, and amortization expense for costs capitalized to obtain revenue contracts during the nine months ended September 30, 2022 and 2021 was $6.9 million and $4.8 million, respectively. |
Cost of Revenue | Cost of Revenue Subscription Cost of Revenue Subscription cost of revenue consists of three categories of expenses: UserTesting Contributor Network, platform, and support. UserTesting Contributor Network costs consist primarily of contributor payments for the tests completed as well as the cost to operate and support those contributors. Platform costs consist primarily of the cost to support the Company’s platform, including infrastructure-related, hosting, and personnel-related costs, such as salaries, bonus, stock-based compensation expense, and benefits. Support costs include the personnel-related costs, such as salaries, bonus, stock-based compensation expense, and benefits, of employees who directly support customers of the Company’s subscription services and amortization of acquired intangibles. Professional Services Cost of Revenue Professional services cost of revenue consists primarily of personnel-related costs, third-party consulting expenses, and allocated overhead. |
Software Development Costs and Research and Development | Software Development Costs Software development costs include costs to develop software to be used to meet internal needs and applications used to deliver the Company’s services. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed and the software will be used to perform the function intended. Costs capitalized for developing such software applications were not material for the three and nine months ended September 30, 2022 and 2021. Research and Development Research and development expenses primarily consist of personnel-related expenses, including stock-based compensation directly associated with the Company’s research and development employees, contractor costs related to third-party development, and allocated overhead. Research and development costs are expensed as incurred. |
Advertising Costs | Advertising Costs Advertising costs are expensed as incurred in sales and marketing expense in the condensed consolidated statements of operations and were $2.0 million and $3.0 million for the three months ended September 30, 2022 and 2021, respectively, and $7.3 million and $7.2 million for the nine months ended September 30, 2022 and 2021, respectively. |
Leases | Leases The Company categorizes lease agreements at their inception as either operating or finance leases. Operating lease right-of-use (ROU) assets and related liabilities are included in “Operating lease right-of-use assets,” “Operating lease liabilities, current,” and “Operating lease liabilities, non-current” in the Company’s condensed consolidated balance sheets. The Company did not have any finance leases. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date, including credit premiums on its corporate borrowings, in determining the present value of lease payments. The operating lease ROU asset also includes any advance lease payments made and excludes lease incentives, where applicable. The Company’s lease terms may contain renewal and extension options of up to three years and early termination features. The Company does not include renewal or extension options or early termination features in its determination of the lease term to the extent they are not reasonably certain at lease commencement. Lease expense for lease payments to the extent they are fixed is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor to the extent the charges are variable. The Company has elected to combine non-lease components with lease components for the purposes of calculating the ROU asset and liabilities, to the extent they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease costs. In addition, the Company does not recognize ROU assets and lease liabilities for short-term leases, which have a lease term of 12 months or less at the commencement of the lease. In addition, the Company subleases its unoccupied facility to a third party. Such sublease has been classified as an operating lease. Any impairment to the associated ROU assets, leasehold improvements, or other assets as a result of a sublease is recognized in the period the sublease is executed and recorded in the condensed consolidated statements of operations. The Company recognizes sublease income on a straight-line basis over the sublease term. |
Stock-Based Compensation | Stock-Based Compensation The Company has a stock incentive plan under which equity awards such as stock options, restricted stock awards (RSAs), and restricted stock units (RSUs) are granted to employees, directors, and/or consultants. Stock-based compensation expense related to equity awards is recognized based on the fair value of the awards on the date of grant. The fair value of each stock option is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of subjective assumptions, including the fair value of the underlying common stock, risk-free interest rates, the expected term of the option, expected volatility, and expected dividend yield. The expected term of the stock options is based on the average period the stock options are expected to remain outstanding, calculated as the midpoint of the option’s vesting term and the contractual expiration period, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The expected stock price volatility for the Company’s stock was determined by examining the historical volatilities of its industry peers as the Company did not have a relevant trading history of its common stock. The risk-free interest rate was calculated using the average of the published interest rates of U.S. Treasury zero-coupon issues with maturities that approximate the expected term. The dividend yield assumption is zero as the Company has no history of, nor plans of, dividend payments. The fair value of each RSA and RSU is estimated based on the fair value of the Company’s common stock on the date of grant. The related stock-based compensation expense for time-based equity awards is recognized on a straight-line basis over the corresponding requisite service period of the awards, which is generally four years. The Company also has a 2021 Employee Stock Purchase Plan (2021 ESPP) under which stock purchase rights are granted to employees. Stock-based compensation expense related to stock purchase rights under the 2021 ESPP is recognized based on the fair value of the awards on the date of grant. The fair value of each stock purchase right under the 2021 ESPP is estimated on the grant date using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of assumptions, including the fair value of the underlying common stock, risk-free interest rates, the applicable purchase periods within an offering period, expected volatility, and expected dividend yield. The related stock-based compensation expense for stock purchase rights under the 2021 ESPP is recognized on a straight-line basis over the award’s requisite service period, which is an offering period. The Company accounts for forfeitures as they occur. Prior to the IPO, the fair value of the Company’s common stock underlying the awards was determined by the Company’s board of directors with input from management and third-party valuation specialists. The board of directors determined the fair value of the common stock by considering a number of objective and subjective factors including: the valuation of comparable companies, the Company’s operating and financial performance, the lack of liquidity of common stock, transactions in the Company’s common stock, and general and industry specific economic outlook, amongst other factors. After the IPO, the Company uses the publicly quoted price as reported on the New York Stock Exchange as the fair value of its common stock. In September 2021, the Company granted RSUs which vest based upon the satisfaction of both a service-based condition and a liquidity event-based condition. The service-based vesting condition for these awards is generally satisfied over four years. The liquidity event-based vesting condition is satisfied upon the occurrence of a qualifying event, which is generally defined as an underwritten initial public offering or a change in control transaction. The related stock-based compensation expense for these awards is recognized using an accelerated attribution method from the time it is deemed probable that the liquidity event-based vesting condition will be met through the time the service-based vesting condition has been achieved. The Company began recognizing stock-based compensation expense for these RSUs in November 2021 when the liquidity event-based vesting condition applicable to these RSUs was satisfied upon the effectiveness of the Company’s IPO. |
Foreign Currency | Foreign Currency The functional currency of the Company’s foreign subsidiaries is the U.S. Dollar (USD). Monetary assets and liabilities are remeasured using foreign currency exchange rates at the end of the period, and non-monetary assets and liabilities are remeasured based on historical exchange rates. Gains and losses due to foreign currency are the result of either the remeasurement of subsidiary balances or transactions denominated in currencies other than the foreign subsidiaries’ functional currency and are included in other income (expense), net in the Company’s condensed consolidated statements of operations. |
Income Taxes | Income Taxes The Company uses the asset and liability method of accounting for income taxes, in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the condensed consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be reversed. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates as income and expense in the period that includes the enactment date. A valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. In determining the need for a valuation allowance, the Company considers future growth, forecasted earnings, future taxable income, the mix of earnings in the jurisdictions in which the Company operates, historical earnings and losses carryforward periods, and prudent and feasible tax planning strategies, as applicable. |
Net Loss Per Share | Net Loss Per Share Prior to the automatic conversion of all the shares of the Company’s outstanding convertible preferred stock into shares of common stock upon the closing of the Company’s IPO, holders of the Company’s common stock were not entitled to dividends until declared dividends to holders of the Company’s convertible preferred stock have been paid. The Company was required to use the two-class method of calculating earnings per share. The two-class method requires that earnings per share be calculated separately for each class of security. As the Company incurred losses during the periods presented, the Company used the methods described below to calculate net loss per share. The Company calculates basic net loss per share by dividing net loss attributable to common stockholders by the weighted-average number of the Company’s shares of common stock outstanding during the respective period. Net loss attributable to common stockholders is net loss minus convertible preferred stock dividends declared, of which there were none during the periods presented. |
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted | Recently Adopted Accounting Standards In August 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract , which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this new guidance. This new guidance is effective for the Company for its fiscal year beginning January 1, 2022, and may be adopted either prospectively or retrospectively to all implementation costs incurred after the date of adoption. The Company adopted this guidance effective January 1, 2022, and the adoption did not have a material impact on its condensed consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes in order to reduce cost and complexity of its application. This new guidance is effective for the Company for its fiscal year beginning January 1, 2022, and interim periods within its fiscal year beginning January 1, 2023, and early adoption is permitted. Most amendments within this guidance are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance effective January 1, 2022, and the adoption did not have a material impact on its condensed consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments Topic 326: Credit Losses Measurement of Credit Losses on Financial Instruments (Topic 326) , which requires an entity to utilize a new impairment model known as the current expected credit loss (CECL) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. This guidance also requires new disclosures for financial assets measured at amortized cost, loans, and available-for-sale debt securities. Entities will apply the standard’s provisions as a cumulative effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. Topic 326 is effective for the Company for its fiscal year beginning January 1, 2023. The Company does not expect the adoption of this standard will have a material impact on its condensed consolidated financial statements. |
Summary of Business and Signi_3
Summary of Business and Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Summary of Property and Equipment, by Geographic Region | The following table presents the Company’s property and equipment, net of accumulated depreciation and amortization, by geographic region (in thousands): September 30, December 31, United States $ 2,178 $ 2,738 United Kingdom 711 510 Rest of the world 27 9 Total property and equipment, net $ 2,916 $ 3,257 Property and equipment, net consisted of the following (in thousands): September 30, December 31, Computer, equipment, and software $ 2,879 $ 2,632 Furniture and fixtures 393 357 Leasehold improvements 2,067 1,822 Property and equipment, gross 5,339 4,811 Less: accumulated depreciation (2,423) (1,554) Property and equipment, net $ 2,916 $ 3,257 |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Summary of Contract Liabilities | Contract liabilities consisted of the following (in thousands): September 30, December 31, Deferred revenue $ 91,714 $ 84,494 Customer deposits 5,117 6,458 Contract liabilities $ 96,831 $ 90,952 |
Disaggregation of Revenue | The following table sets forth revenue by geographic area for the periods presented: Three Months Ended September 30, 2022 2021 (in thousands) % (in thousands) % United States $ 38,845 79 % $ 31,444 81 % International 10,563 21 7,201 19 Total revenue $ 49,408 100 % $ 38,645 100 % Nine Months Ended September 30, 2022 2021 (in thousands) % (in thousands) % United States $ 113,278 79 % $ 86,082 82 % International 29,544 21 18,832 18 Total revenue $ 142,822 100 % $ 104,914 100 % |
Consolidated Balance Sheet Co_2
Consolidated Balance Sheet Components (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Summary of Property and Equipment, Net | The following table presents the Company’s property and equipment, net of accumulated depreciation and amortization, by geographic region (in thousands): September 30, December 31, United States $ 2,178 $ 2,738 United Kingdom 711 510 Rest of the world 27 9 Total property and equipment, net $ 2,916 $ 3,257 Property and equipment, net consisted of the following (in thousands): September 30, December 31, Computer, equipment, and software $ 2,879 $ 2,632 Furniture and fixtures 393 357 Leasehold improvements 2,067 1,822 Property and equipment, gross 5,339 4,811 Less: accumulated depreciation (2,423) (1,554) Property and equipment, net $ 2,916 $ 3,257 |
Summary of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, December 31, Sales tax payable $ 641 $ 5,528 Accrued compensation and benefits 4,159 7,218 Accrued tax liabilities 2,544 2,805 ESPP liability 1,559 466 Others 3,633 5,782 Accrued expenses and other current liabilities $ 12,536 $ 21,799 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Summary of Lease Costs | Total operating lease costs, excluding short-term lease costs, variable lease costs, and sublease income, each of which were immaterial for the periods presented, were as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Operating lease costs $ 1,496 $ 1,365 $ 4,499 $ 4,325 Supplemental cash flow information related to leases were as follows (in thousands): Nine Months Ended September 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,635 $ 3,931 Right-of-use assets obtained in exchange for lease obligations: Operating leases 372 1,010 The weighted-average remaining lease term and discount rate for the Company’s operating leases were as follows: September 30, December 31, Weighted-average remaining lease term 2.7 years 3.3 years Weighted-average discount rate 5.8% 5.8% |
Schedule of Operating Lease Maturity | The total remaining lease payments under non-cancelable operating leases as of September 30, 2022 were as follows (in thousands): Remainder of 2022 $ 1,522 2023 5,696 2024 5,147 2025 3,368 Total undiscounted lease payments 15,733 Less imputed interest (1,168) Present value of operating lease liabilities $ 14,565 |
Stockholders_ Equity and Equi_2
Stockholders’ Equity and Equity Incentive Plan (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
Schedule of Common Stock Reserved for Future Issuance | The Company had the following shares of common stock reserved for future issuance (in thousands): September 30, December 31, Outstanding stock awards to purchase common stock 26,021 25,181 Stock awards available for future grants 20,538 16,154 Shares available for issuance under 2021 ESPP 4,024 3,100 50,583 44,435 |
Summary of Stock Option Activity | The following table summarizes the stock option activity during the nine months ended September 30, 2022 (in thousands, except per share data): Options Outstanding Outstanding Stock options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value Balance as of December 31, 2021 22,690 $ 1.71 7.56 $ 153,883 Exercised (1,680) 1.34 8,431 Forfeited (1,013) 3.17 Expired (53) 1.66 Balance as of September 30, 2022 19,944 1.66 6.82 48,015 Vested and exercisable: September 30, 2022 14,435 $ 1.22 6.35 $ 39,336 December 31, 2021 11,917 $ 0.96 6.66 $ 88,893 |
Summary of Restricted Stock Unit Activity | The following table summarizes the RSU activity during the nine months ended September 30, 2022 (in thousands, except per share data): Restricted Stock Units Number of Shares Weighted-Average Grant Date Fair Value Balance as of December 31, 2021 2,491 $ 16.11 Granted 4,707 9.21 Vested (207) 9.70 Forfeited (914) 12.12 Balance as of September 30, 2022 6,077 11.59 |
Schedule of Stock Option Valuation Assumptions | The assumptions used under the Black-Scholes option pricing model to calculate the estimated fair value of stock options granted to employees are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Fair value of common stock * $ 10.97 — 17.04 * $ 3.88 — 17.04 Risk-free interest rate * 0.94% — 1.00% * 0.94% — 1.05% Expected term (years) * 5.84 — 6.08 * 5.73 — 6.08 Expected volatility * 55.24% — 56.82% * 54.04% — 56.82% Expected dividend yield * None * None ____________ * No stock options were granted during the periods presented. |
Schedule of ESPP Valuation Assumptions | The following table summarizes the assumptions used to calculate the estimated fair value of stock purchase rights granted under the 2021 ESPP using the Black-Scholes-Merton option pricing model: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Fair value of common stock * * $ 4.52 * Risk-free interest rate * * 1.54% — 2.66% * Expected term (years) * * 0.49 — 1.99 * Expected volatility * * 53.74% — 60.64% * Expected dividend yield * * None * ____________ * No stock purchase rights were granted under the 2021 ESPP during the periods presented. |
Summary of Stock-based Compensation Expense | The total stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of revenue: Subscription $ 211 $ 11 $ 553 $ 30 Professional services 239 78 701 160 Operating expenses: Sales and marketing 2,920 404 9,057 1,079 Research and development 1,384 237 4,574 620 General and administrative 2,562 2,057 7,811 3,030 Total stock-based compensation expense $ 7,316 $ 2,787 $ 22,696 $ 4,919 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except share and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders, basic and diluted $ (15,191) $ (9,636) $ (49,114) $ (33,803) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 144,211 19,558 143,347 18,798 Net loss per share attributable to common stockholders, basic and diluted $ (0.11) $ (0.49) $ (0.34) $ (1.80) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows (in thousands): September 30, 2022 2021 Convertible preferred shares — 110,851 Options and RSUs issued and outstanding 26,021 26,144 ESPP 243 — Total antidilutive securities 26,264 136,995 |
Summary of Business and Signi_4
Summary of Business and Significant Accounting Policies - Narrative (Details) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) segment | Sep. 30, 2021 USD ($) | |
Property, Plant and Equipment [Line Items] | ||||
Number of operating segments | segment | 1 | |||
Sales commissions, amortization period | 4 years | |||
Capitalized contract cost, impairment loss | $ 0 | $ 0 | $ 0 | $ 0 |
Capitalized contract cost, increase (decrease) | 2,200,000 | 3,500,000 | 6,700,000 | 9,000,000 |
Amortization of costs capitalized to obtain revenue contracts | 2,400,000 | 1,800,000 | 6,886,000 | 4,757,000 |
Advertising costs | $ 2,000,000 | $ 3,000,000 | $ 7,300,000 | $ 7,200,000 |
Lessee, operating lease, renewal term | 3 years | 3 years | ||
Award requisite service period | 4 years | |||
Minimum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property and equipment, useful life | 3 years | |||
Maximum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property and equipment, useful life | 5 years |
Summary of Business and Signi_5
Summary of Business and Significant Accounting Policies - Property and Equipment, by Geographic Region (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, net | $ 2,916 | $ 3,257 |
United States | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, net | 2,178 | 2,738 |
United Kingdom | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, net | 711 | 510 |
Rest of the world | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, net | $ 27 | $ 9 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |||||
Capitalized contract cost, impairment loss | $ 0 | $ 0 | $ 0 | $ 0 | |
Contract liabilities | 96,800,000 | 96,800,000 | $ 91,000,000 | ||
Contract liabilities, revenue recognized | 83,600,000 | $ 57,500,000 | |||
Customer deposits and unbilled amounts of cancellable revenue | 5,900,000 | 5,900,000 | |||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01 | |||||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |||||
Revenue, remaining performance obligation, amount | $ 119,800,000 | $ 119,800,000 | |||
Revenue, remaining performance obligation, expected timing of satisfaction, period | 12 months | 12 months | |||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01 | |||||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |||||
Revenue, remaining performance obligation, expected timing of satisfaction, period | 24 months | 24 months |
Revenue - Summary of Contract L
Revenue - Summary of Contract Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Revenue from Contract with Customer [Abstract] | ||
Deferred revenue | $ 91,714 | $ 84,494 |
Customer deposits | 5,117 | 6,458 |
Contract liabilities | $ 96,831 | $ 90,952 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 49,408 | $ 38,645 | $ 142,822 | $ 104,914 |
United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 38,845 | $ 31,444 | $ 113,278 | $ 86,082 |
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
Concentration risk, percentage | 79% | 81% | 79% | 82% |
International | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 10,563 | $ 7,201 | $ 29,544 | $ 18,832 |
International | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
Concentration risk, percentage | 21% | 19% | 21% | 18% |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
Cash and cash equivalents | $ 164,618 | $ 178,430 |
Money Market Funds | Fair Value, Inputs, Level 1 | Fair Value, Recurring | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
Cash and cash equivalents | $ 117,900 | $ 33,600 |
Consolidated Balance Sheet Co_3
Consolidated Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | $ 5,339 | $ 5,339 | $ 4,811 | ||
Less: accumulated depreciation | (2,423) | (2,423) | (1,554) | ||
Property and equipment, net | 2,916 | 2,916 | 3,257 | ||
Depreciation | 300 | $ 200 | 900 | $ 400 | |
Computer, equipment, and software | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 2,879 | 2,879 | 2,632 | ||
Furniture and fixtures | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 393 | 393 | 357 | ||
Leasehold improvements | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | $ 2,067 | $ 2,067 | $ 1,822 |
Consolidated Balance Sheet Co_4
Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Accrued Expenses And Other Current Liabilities [Line Items] | ||
Sales tax payable | $ 641,000 | $ 5,528,000 |
Accrued compensation and benefits | 4,159,000 | 7,218,000 |
Accrued tax liabilities | 2,544,000 | 2,805,000 |
ESPP liability | 1,559,000 | 466,000 |
Others | 3,633,000 | 5,782,000 |
Accrued expenses and other current liabilities | 12,536,000 | 21,799,000 |
Estimate of possible loss, current | 0 | 4,700,000 |
VDA | ||
Accrued Expenses And Other Current Liabilities [Line Items] | ||
Estimate of possible loss (reversal of accrual), current | $ 2,900,000 | $ 4,100,000 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets, Net (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Finite-Lived Intangible Assets [Line Items] | |||||
Goodwill | $ 8,785 | $ 8,785 | $ 8,785 | ||
Amortization of intangible assets | 100 | $ 300 | 200 | $ 800 | |
Developed Technology | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Intangible assets, net | $ 400 | $ 400 | $ 600 |
Debt (Details)
Debt (Details) - Revolving Credit Facility - Security Modification Agreement - Line of Credit - USD ($) | 9 Months Ended | 12 Months Ended | |
Jun. 18, 2021 | Sep. 30, 2022 | Dec. 31, 2021 | |
Line of Credit Facility [Line Items] | |||
Maximum borrowing capacity | $ 5,500,000 | ||
Minimum unrestricted cash balance with lender | $ 5,500,000 | ||
Outstanding borrowings | $ 0 | $ 0 | |
Prime Rate | |||
Line of Credit Facility [Line Items] | |||
Basis spread on variable rate | 3.25% | 6.25% | 3.25% |
Commitments and Contingencies -
Commitments and Contingencies - Lease Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |||||
Operating lease costs | $ 1,496 | $ 1,365 | $ 4,499 | $ 4,325 | |
Cash paid for amounts included in the measurement of lease liabilities: | |||||
Operating cash flows from operating leases | 4,635 | 3,931 | |||
Right-of-use assets obtained in exchange for lease obligations: | |||||
Operating leases | $ 372 | $ 1,010 | |||
Weighted-average remaining lease term | 2 years 8 months 12 days | 2 years 8 months 12 days | 3 years 3 months 18 days | ||
Weighted-average discount rate | 5.80% | 5.80% | 5.80% |
Commitments and Contingencies_2
Commitments and Contingencies - Operating Lease Maturity (Details) $ in Thousands | Sep. 30, 2022 USD ($) |
Lessee, Operating Lease, Liability, Payment, Due [Abstract] | |
Remainder of 2022 | $ 1,522 |
2023 | 5,696 |
2024 | 5,147 |
2025 | 3,368 |
Total undiscounted lease payments | 15,733 |
Less imputed interest | (1,168) |
Present value of operating lease liabilities | $ 14,565 |
Stockholders_ Equity and Equi_3
Stockholders’ Equity and Equity Incentive Plan - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||
Nov. 30, 2021 | Oct. 31, 2021 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | Jun. 30, 2007 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||
Common stock reserved for future issuance (in shares) | 50,583,000 | 50,583,000 | 44,435,000 | ||||||
Granted (in shares) | 0 | 0 | 0 | ||||||
Granted (in dollars per share) | $ 4.05 | ||||||||
Total stock-based compensation expense | $ 7,316 | $ 2,787 | $ 22,696 | $ 4,919 | |||||
Option | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Unrecognized stock-based compensation expense | $ 12,100 | $ 12,100 | |||||||
Unrecognized stock-based compensation expense, period for recognition | 2 years 6 months | ||||||||
Options and RSUs issued and outstanding | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 20,538,000 | 20,538,000 | 16,154,000 | ||||||
ESPP | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 4,024,000 | 4,024,000 | 3,100,000 | ||||||
Granted (in shares) | 0 | 0 | 0 | ||||||
Unrecognized stock-based compensation expense | $ 2,800 | $ 2,800 | |||||||
Unrecognized stock-based compensation expense, period for recognition | 1 year 7 months 6 days | ||||||||
Fair value of common stock (in dollars per share) | $ 4.52 | $ 4.52 | |||||||
Restricted Stock Units (RSUs) | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 4 years | ||||||||
Granted (in shares) | 2,490,942 | 4,707,000 | |||||||
Granted (in dollars per share) | $ 16.11 | $ 9.21 | |||||||
Total stock-based compensation expense | $ 3,300 | $ 11,900 | |||||||
Unrecognized stock-based compensation expense | $ 50,500 | $ 50,500 | |||||||
Unrecognized stock-based compensation expense, period for recognition | 3 years | ||||||||
2007 Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares authorized (in shares) | 500,000 | ||||||||
2021 Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 15,700,000 | ||||||||
Common stock reserved for future issuance, automatic increase | 10 years | ||||||||
Common stock reserved for future issuance, automatic increase, percentage | 5% | ||||||||
2021 Plan | Option | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Purchase price of common stock, minimum, percent | 100% | ||||||||
Significant shareholder threshold percentage ownership | 10% | ||||||||
Purchase price for significant shareholders, minimum | 110% | ||||||||
Expiration period | 10 years | ||||||||
Award vesting period | 4 years | ||||||||
2021 Plan | Incentive Stock Option | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Significant shareholder threshold percentage ownership | 10% | ||||||||
Expiration period | 5 years | ||||||||
2021 Plan | Options and RSUs issued and outstanding | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 20,538,259 | 20,538,259 | 16,153,747 | ||||||
2021 ESPP | ESPP | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock reserved for future issuance (in shares) | 3,100,000 | 4,024,434 | 4,024,434 | 3,100,000 | |||||
Common stock reserved for future issuance, automatic increase | 10 years | ||||||||
Common stock reserved for future issuance, automatic increase, percentage | 1% | ||||||||
Purchase price of common stock, minimum, percent | 85% | ||||||||
Maximum shares issued (in shares) | 31,000,000 | ||||||||
Maximum offering period | 27 months | ||||||||
IPO | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock, par value (in dollars per share) | $ 0.0001 | ||||||||
Preferred stock, par value (in dollars per share) | $ 0.0001 | ||||||||
Common Stock | IPO | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Sale of stock, number of shares issued in transaction (in shares) | 2,000,000,000 | ||||||||
Preferred Stock | IPO | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Sale of stock, number of shares issued in transaction (in shares) | 10,000,000 |
Stockholders_ Equity and Equi_4
Stockholders’ Equity and Equity Incentive Plan - Common Stock Reserved for Future Issuance (Details) - shares shares in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Class of Stock [Line Items] | ||
Common stock reserved for future issuance (in shares) | 50,583 | 44,435 |
Outstanding stock awards to purchase common stock | ||
Class of Stock [Line Items] | ||
Common stock reserved for future issuance (in shares) | 26,021 | 25,181 |
Stock awards available for future grants | ||
Class of Stock [Line Items] | ||
Common stock reserved for future issuance (in shares) | 20,538 | 16,154 |
Shares available for issuance under 2021 ESPP | ||
Class of Stock [Line Items] | ||
Common stock reserved for future issuance (in shares) | 4,024 | 3,100 |
Stockholders_ Equity and Equi_5
Stockholders’ Equity and Equity Incentive Plan - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) $ / shares shares | |
Outstanding Stock options | ||
Balance at beginning of period (in shares) | shares | 22,690 | |
Exercised (in shares) | shares | (1,680) | |
Forfeited (in shares) | shares | (1,013) | |
Expired (in shares) | shares | (53) | |
Balance at end of period (in shares) | shares | 19,944 | 22,690 |
Weighted-Average Exercise Price | ||
Balance at beginning of period (in dollars per share) | $ / shares | $ 1.71 | |
Exercised (in dollars per share) | $ / shares | 1.34 | |
Forfeited (in dollars per share) | $ / shares | 3.17 | |
Expired (in dollars per share) | $ / shares | 1.66 | |
Balance at end of period (in dollars per share) | $ / shares | $ 1.66 | $ 1.71 |
Stock Options, Additional Disclosures | ||
Weighted-average remaining contractual life, outstanding | 6 years 9 months 25 days | 7 years 6 months 21 days |
Aggregate intrinsic value, outstanding | $ | $ 48,015 | $ 153,883 |
Aggregate intrinsic value, exercised | $ | $ 8,431 | |
Outstanding stock options, vested and exercisable (in shares) | shares | 14,435 | 11,917 |
Weighted-average exercise price, vested and exercisable (in dollars per share) | $ / shares | $ 1.22 | $ 0.96 |
Weighted-average remaining contractual life, vested and exercisable | 6 years 4 months 6 days | 6 years 7 months 28 days |
Aggregate intrinsic value, vested and exercisable | $ | $ 39,336 | $ 88,893 |
Stockholders_ Equity and Equi_6
Stockholders’ Equity and Equity Incentive Plan - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) - $ / shares | 1 Months Ended | 9 Months Ended |
Sep. 30, 2021 | Sep. 30, 2022 | |
Number of Shares | ||
Balance at beginning of period (in shares) | 2,491,000 | |
Granted (in shares) | 2,490,942 | 4,707,000 |
Vested (in shares) | (207,000) | |
Forfeited (in shares) | (914,000) | |
Balance at end of period (in shares) | 6,077,000 | |
Weighted-Average Grant Date Fair Value | ||
Balance at beginning of period (in dollars per share) | $ 16.11 | |
Granted (in dollars per share) | $ 16.11 | 9.21 |
Vested (in dollars per share) | 9.70 | |
Forfeited (in dollars per share) | 12.12 | |
Balance at end of period (in dollars per share) | $ 11.59 |
Stockholders_ Equity and Equi_7
Stockholders’ Equity and Equity Incentive Plan - Valuation Assumptions (Details) - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Granted (in shares) | 0 | 0 | 0 | |
Option | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Risk-free interest rate, minimum | 0.94% | 0.94% | ||
Risk-free interest rate, maximum | 1% | 1.05% | ||
Expected volatility, minimum | 55.24% | 54.04% | ||
Expected volatility, maximum | 56.82% | 56.82% | ||
Expected dividend yield | 0% | 0% | ||
ESPP | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Fair value of common stock (in dollars per share) | $ 4.52 | $ 4.52 | ||
Risk-free interest rate, minimum | 1.54% | |||
Risk-free interest rate, maximum | 2.66% | |||
Expected volatility, minimum | 53.74% | |||
Expected volatility, maximum | 60.64% | |||
Expected dividend yield | 0% | |||
Granted (in shares) | 0 | 0 | 0 | |
Minimum | Option | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected term (years) | 5 years 10 months 2 days | 5 years 8 months 23 days | ||
Minimum | Option | Valuation Assumptions, Period One | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Fair value of common stock (in dollars per share) | $ 10.97 | $ 10.97 | ||
Minimum | Option | Valuation Assumptions, Period Two | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Fair value of common stock (in dollars per share) | $ 3.88 | $ 3.88 | ||
Minimum | ESPP | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected term (years) | 5 months 26 days | |||
Maximum | Option | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected term (years) | 6 years 29 days | 6 years 29 days | ||
Maximum | Option | Valuation Assumptions, Period One | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Fair value of common stock (in dollars per share) | $ 17.04 | $ 17.04 | ||
Maximum | Option | Valuation Assumptions, Period Two | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Fair value of common stock (in dollars per share) | $ 17.04 | $ 17.04 | ||
Maximum | ESPP | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected term (years) | 1 year 11 months 26 days |
Stockholders_ Equity and Equi_8
Stockholders’ Equity and Equity Incentive Plan - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | $ 7,316 | $ 2,787 | $ 22,696 | $ 4,919 |
Sales and marketing | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 2,920 | 404 | 9,057 | 1,079 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 1,384 | 237 | 4,574 | 620 |
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 2,562 | 2,057 | 7,811 | 3,030 |
Subscription | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 211 | 11 | 553 | 30 |
Professional services | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | $ 239 | $ 78 | $ 701 | $ 160 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Provision for income taxes | $ 307 | $ 275 | $ 508 | $ 569 |
Effective income tax rate reconciliation, percent | (2.10%) | (2.90%) | (1.00%) | (1.70%) |
Net Loss Per Share - Earnings P
Net Loss Per Share - Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Numerator: | ||||
Net loss attributable to common stockholders, basic | $ (15,191) | $ (9,636) | $ (49,114) | $ (33,803) |
Net loss attributable to common stockholders, diluted | $ (15,191) | $ (9,636) | $ (49,114) | $ (33,803) |
Denominator: | ||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 144,211 | 19,558 | 143,347 | 18,798 |
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 144,211 | 19,558 | 143,347 | 18,798 |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.11) | $ (0.49) | $ (0.34) | $ (1.80) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.11) | $ (0.49) | $ (0.34) | $ (1.80) |
Net Loss Per Share - Antidiluti
Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total antidilutive securities (in shares) | 26,264,000 | 136,995,000 |
Convertible preferred shares | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total antidilutive securities (in shares) | 0 | 110,851,000 |
Options and RSUs issued and outstanding | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total antidilutive securities (in shares) | 26,021,000 | 26,144,000 |
ESPP | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total antidilutive securities (in shares) | 243,000 | 0 |
Employee Benefit Plans (Details
Employee Benefit Plans (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Retirement Benefits [Abstract] | ||||
Employer matching contribution, percent of employees' gross pay | 4% | 4% | ||
Contributions per employee, automatic deferral, percent | 5% | |||
Employers matching contribution, annual vesting percentage | 100% | |||
Defined contribution plan, cost | $ 0.8 | $ 0.7 | $ 2.6 | $ 2.2 |
Restructuring (Details)
Restructuring (Details) $ in Millions | 1 Months Ended |
Jul. 31, 2022 USD ($) | |
Restructuring and Related Activities [Abstract] | |
Employee termination, percent | 7% |
Termination benefits | $ 1.4 |
Subsequent Event (Details)
Subsequent Event (Details) - Forecast - Usertesting, Inc. $ / shares in Units, $ in Millions | 6 Months Ended |
Dec. 31, 2023 USD ($) $ / shares | |
Subsequent Event [Line Items] | |
Contingent consideration, liability | $ 33.9 |
Contingent consideration, asset | $ 67.8 |
Thoma Bravo | |
Subsequent Event [Line Items] | |
Business acquisition, share price (in dollars per share) | $ / shares | $ 7.50 |
Business combination, consideration transferred | $ 1,300 |